Trials / Unknown
UnknownNCT01233739
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis. Measurement With Sensory and Quantitive Functional Tests and Concordance Analysis With Subjective Scales of Pain.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- Sponsor
- Juan A. Arnaiz · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients who present rhizarthrosis diagnostic will be randomized to be treated with chondroitin sulfate or placebo during 24 weeks to study the effect of the treatment with objective and subjective indicators of pain and sensibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chondroitin sulfate | Administration of 2 capsules of 400 mg of chondroitin sulfate orally. |
| DRUG | Placebo | Administration of 2 capsules of placebo orally. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2010-11-03
- Last updated
- 2013-02-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01233739. Inclusion in this directory is not an endorsement.